Last reviewed · How we verify

NCT04386590

Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease.

Status unknown Phase 2, PHASE3 Last updated 31 March 2022
What this trial tests

Phase 2, PHASE3 trial testing Manual Therapy Plus Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Moderate in 20 participants. Status unknown.

Timeline
15 June 2022
Primary endpoint
31 May 2023
2 November 2023

Quick facts

Lead sponsorCanandaigua VA Medical Center
PhasePhase 2, PHASE3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date15 June 2022
Primary completion31 May 2023
Estimated completion2 November 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Canandaigua VA Medical Center

Who can join

Adults 50 to 70, any sex, with Chronic Obstructive Pulmonary Disease Moderate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the feasibility of administering this combination of interventions (CMT plus PR) to Veterans with moderate COPD within the context of a hospital-based outpatient pulmonary rehabilitation program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Obstructive Pulmonary Disease Moderate

Currently open trials in the same condition.

Other Canandaigua VA Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04386590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing